Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Granberry-D-GRL
- Development stage
- Unknown
- Lead developer
- GRL
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Granberry-D-GRL** is a marketed GRL gynecology product listed by GRL Pharma, but the company website does not disclose its full composition or labeling details. Based on external marketplace references for similarly named products, it appears to be an **oral cranberry and D-mannose urinary health product**, likely positioned for prevention or supportive management of recurrent urinary tract infections in women rather than as a novel investigational therapy. Because the exact formulation, strengths, and regulatory classification are not provided by GRL Pharma, its precise active ingredients and mechanism should be treated as incompletely confirmed.
- Brand names
- Granberry-DGranberry-D-GRL
Beyond the preview
Go deeper on Granberry-D-GRL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Granberry-D-GRL.